Filter
1226
Filtered Results: 1226
Text search:
re-emergence
Featured
Recommendations
130
New Publications
310
Language
Document type
No document type
617
Studies & Reports
256
Guidelines
178
Strategic & Response Plan
80
Manuals
53
Fact sheets
17
Training Material
12
Situation Updates
7
Infographics
3
Online Courses
2
Resource Platforms
1
Countries / Regions
India
49
Global
49
Sierra Leone
32
Liberia
30
Latin America and the Carribbean
30
South Africa
29
Africa
27
Nigeria
26
Western and Central Europe
25
Ethiopia
23
Uganda
23
Venezuela
20
Tanzania
18
Kenya
17
Nepal
15
Syria
15
Argentina
15
Colombia
15
Guinea
14
Zambia
14
Bangladesh
14
Paraguay
14
Myanmar / Burma
13
Ghana
12
Namibia
11
West and Central Africa
11
Malawi
10
Brazil
10
Bolivia
10
Eastern Europe
10
Pakistan
9
Congo, Democratic Republic of
8
Ecuador
8
Afghanistan
7
Peru
7
East and Southern Africa
7
South–East Asia Region
7
Senegal
6
Cambodia
6
Ukraine
6
Zimbabwe
5
Rwanda
5
Burkina Faso
4
South Sudan
4
Iraq
4
Jordan
4
Germany
4
Central African Republic
4
Eswatini/ Swaziland
4
El Salvador
4
Chile
4
Western Pacific Region
4
USA
3
Cameroon
3
Haiti
3
Somalia
3
Lebanon
3
Thailand
3
Madagascar
3
Middle East and North Africa
3
Asia
3
Italy
3
Georgia
3
Côte d’Ivoire / Ivory Coast
2
Niger
2
Turkey
2
Indonesia
2
Mozambique
2
Sudan
2
North Macedonia
2
Botswana
2
Greece
2
Libya
2
Angola
2
Lesotho
2
Yemen
2
Russia
2
Moldova
2
Iran
2
Tunisia
2
Mali
1
Morocco
1
Saudi Arabia
1
Philippines
1
Chad
1
China
1
Papua New Guinea
1
Benin
1
Serbia
1
Croatia
1
Eastern Europe and Central Asia
1
Other region
1
Bhutan
1
Albania
1
Armenia
1
Laos
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Uruguay
1
Belgium
1
Mauritius
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
455
Clinical Guidelines
91
Public Health
69
Key Resources
48
Women & Child Health
26
Pharmacy & Technologies
22
Capacity Building
10
Toolboxes
COVID-19
131
TB
111
AMR
93
Rapid Response
81
Planetary Health
74
NTDs
60
Mental Health
59
HIV
51
Ebola
50
Polio
30
Global Health Education
22
Conflict
21
Refugee
17
Disability
15
Caregiver
13
Natural Hazards
11
Pharmacy
10
Zika
9
Health Financing Toolbox
8
Cholera
7
Specific Hazards
7
Social Ethics
4
NCDs
3
Typhoon
2
WHO Technical Series 971
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
The guideline on Drug misuse: opioid detoxification, commissioned by NICE and developed by the National Collaborating Centre for Mental Health, sets out clear, evidence-based recommendations for healthcare staff on how to work with people who misuse opioids to significantly improve their treatment a...
The African Region has been experiencing unprecedented health challenges due to the Coronavirus disease 2019 (COVID-19) pandemic, which have compounded the already difficult task the Region was facing in moving towards universal health coverage (UHC) attainment.
This annual report highlights the work of the WHO from January to June 2021 ( December 2021). The activities featured herein are by no means exhausted but implemented with technical and financial support through WHO in Nigeria; facilitated by its presence at all levels of governance (national, state...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable development, human rights, and peace that governments are...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Policy Brief. More languages available here https://apps.who.int/iris/handle/10665/179517
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
